by aceventadm | Sep 24, 2026 | News & Insights
Prevision Medicine, a transformative precision oncology startup, today announced it has successfully raised $5.4 million in its Seed round. The funding will accelerate the commercialization of its groundbreaking functional precision medicine test for hematological...
by aceventadm | Aug 26, 2026 | News & Insights
The bottleneck nobody talks about AI has made it easy to design proteins. Many teams can now create thousands of candidate molecules for a target in an afternoon. Finding out whether those molecules actually work is still the hard part. That requires a wet lab. But...
by aceventadm | Jan 30, 2026 | News & Insights
LAUSANNE, Switzerland and SAN FRANCISCO, Jan. 28, 2026 /PRNewswire/ — Scholé AI, an AI-native learning platform built for the modern workforce, today announced it has raised $3 million in funding led by ACE Ventures, with participation from The House Fund and...
by aceventadm | Sep 25, 2025 | News & Insights
ACE Ventures led the $8 million seed round in Adaptyv Bio, a Swiss biotechnology company redefining how proteins are designed, tested, and brought to market. Adaptyv Bio has officially launched its platform to the broader scientific community, enabling rapid testing...
by aceventadm | Sep 22, 2025 | News & Insights
ZURICH, Switzerland, Sept. 22, 2025 — Veezoo is the most mature Agentic Analytics platform that empowers everyone to ask the right questions and get insights they can trust. Since 2016, Veezoo has been designed from the ground up as an AI-native platform for Agentic...
by aceventadm | Jul 1, 2025 | News & Insights
At Investor Day 2025, ACE Ventures spotlighted the entrepreneurs who are not just shaping markets, but pushing the boundaries of what is possible. From hydrogen-powered hypersonic flight to the automation of protein engineering, the sessions revealed ACE’s commitment...
